AFC-HD AMS Life Science Co. Ltd. also released the following forecasts:
GROUP Year Ending
Aug 2026
Revenue Y34.14 bln
Operating Profit Y2.55 bln
Pretax Profit Y2.45 bln
Net Profit Y1.55 bln
Per share
Earnings Y106.13
Results are based on Japanese accounting standards.
This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
(END) Dow Jones Newswires
April 14, 2026 02:37 ET (06:37 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.